2012 Year in Review 


With a new year underway, the International Psoriasis Council invites our dedicated supporters, associates and partners to take a retrospective look in order to review the organization's many achievements over this past year.  2012 was a successful year for the IPC, as we reaffirmed our commitment to education, research and the treatment of psoriasis, by creating a larger network of key opinion leaders and educating more physicians around the world.  This could not have been done without your hard work and support.  We thank you for your continued dedication and assistance and we look forward to an even bigger year in 2013.

Without further ado, IPC's year in review:

Launched new website  

This includes a comprehensive Psoriasis Image Library, past editions of the IPC Psoriasis Review Newsletter and educational webcasts available for CME credits. Web traffic was increased by 40% overall, with a significant increase in visitors from Asia and South America.

Appointed new councilors

Fifteen new Councilors were appointed who will contribute their expertise and assistance to our organization and our various projects throughout the year.

Initiated a groundbreaking global genetics project

This project is designed to identify rare susceptibility alleles and the functional characterization of causal susceptibility variants. The results are expected to contribute a wealth of knowledge that may facilitate the design of targeted treatments, the development of prognostic markers, and the prediction of drug responsiveness, that could greatly benefit the psoriasis patient.

Held a record number of Meet the Experts programs

Reaching over 1,000 medical professionals, programs were held throughout the world including: Maui, Hawaii; Huntington Beach, California; Prague, Czech Republic; Mandaluyong City, Philippines; Durban, South Africa; Buenos Aires, Argentina and Stockholm, Sweden.

Published five manuscripts in top tier scientific journals

The severity of pediatric psoriasis correlates with risk of obesity: An international multi-center controlled assessment. (2012) A. S. Paller et al. Archives of Dermatology, in press.

The quest for psoriasis susceptibility genes in the post-GWAS era: charting the road ahead. (2012) F. Capon and J. N. Barker. British Journal of Dermatology, 166; 1173-1175.

Psoriasis, a Proof of Principle Condition for Immune-Mediated Inflammatory Disorders: Perspectives Toward Optimal Clinical Trial Design. (2012) Kristen Corey, Peter Mattei, Neil Houston, Paul W. Tebbey, Peter C.M. van de Kerkhof, and Alexa Boer Kimball for the International Psoriasis Council. Clin. Invest. (2012) 2(7), 671-678

Long-Term Management of Scalp Psoriasis: Perspectives from the International Psoriasis Council. (2012) Knud Kragballe, MD, Alan Menter, MD, PhD, Mark Lebwohl, MD, Paul W. Tebbey, PhD and Peter C.M. van de Kerkhof, MD, PhD for the International Psoriasis Council. Dermatology Treat. 2012 Jun 5. [Epub ahead of print]

Biopharmaceuticals and Biosimilars in Psoriasis: What the Dermatologist Needs to Know. (2012) B.E. Strober, K. Armour, R. Romiti, C. Smith, P.W. Tebbey, A. Menter and C. Leonardi, on behalf of the International Psoriasis Council. Journal of the American Academy of Dermatology. 66 (2)317-322.

In 2013 we will bring educational programs to Asia and Eastern and Western Europe. We will do further research into the genetic basis of psoriasis and begin our in-depth exploration of co-morbidities associated with psoriasis. We look forward to your continued support of our organization and wish you a Happy New Year!

Best regards,

Peter van de Kerkhof
President, IPC

*To access additional content on our Website, log-in using your email address and the password psoriasis12.

Kamloops Symphony Newsletter
View this email in your browser

Powered by SiteCMTM — Web Content & eNewsletter Management by ideaLEVER Solutions.